SOCS36E, a novel Drosophila SOCS protein, suppresses JAK/STAT and EGF-R signalling in the imaginal wing discCALLUS, Bernard A; MATHEY-PREVOT, Bernard.Oncogene (Basingstoke). 2002, Vol 21, Num 31, pp 4812-4821, issn 0950-9232, 10 p.Article

Les thérapeutiques ciblées en oncologie thoracique = Targeted therapies in thoracic oncologyQUOIX, E; BEAU-FALLER, M; DOUILLARD, J.-Y et al.Revue des maladies respiratoires. 2004, Vol 21, Num 3, pp 527-537, issn 0761-8425, 11 p., CAH1Article

Périonyxis secondaire aux inhibiteurs de I'EGF-R : quel traitement en cas d'échec des traitements topiques ? = Epidermal growth factor receptor inhibitor : which treatment when topical therapy failed?THELLIER, S; WIERZBICKA-HAINAUT, E; GUILLET, G et al.Les Nouvelles dermatologiques. 2009, Vol 28, Num 3, pp 171-172, issn 0752-5370, 2 p.Conference Paper

Inhibition of PI3k, mTOR and MEK signaling pathways promotes rapid apoptosis in B-lineage ALL in the presence of stromal cell supportBERTRAND, F. E; SPENGEMEN, J. D; SHELTON, J. G et al.Leukemia. 2005, Vol 19, Num 1, pp 98-102, issn 0887-6924, 5 p.Article

Mechanisms behind COX-1 and COX-2 inhibition of tumor growth in vivoAXELSSON, Hans; LÖNNROTH, Christina; ANDERSSON, Marianne et al.International journal of oncology. 2010, Vol 37, Num 5, pp 1143-1152, issn 1019-6439, 10 p.Article

Keratinocyte growth factor receptor (KGF-R) in cholesteatoma tissueBARBARA, M; RAFFA, S; MURE, C et al.Acta oto-laryngologica. 2008, Vol 128, Num 4, pp 360-364, issn 0001-6489, 5 p.Article

Serum concentrations of growth factors in women with and without endometriosis: the action of anti-endometriosis medicinesMATALLIOTAKIS, I. M; GOUMENOU, A. G; KOUMANTAKIS, G. E et al.International immunopharmacology. 2003, Vol 3, Num 1, pp 81-89, issn 1567-5769, 9 p.Article

Quel traitement de première ligne en cas de mutation activatrice de l'EGFR dans les cancers bronchiques non à petites cellules (CBNPC) disséminés ? = First-line treatment in case of activating EGFR mutations in diffuse NSCLCEMERY, M; CADRANEL, J.Revue des maladies respiratoires actualités (Print). 2014, Vol 6, Num 2, pp 136-139, issn 1877-1203, 4 p.Article

Correlation of different markers (p53, EGF-R, c-erbB-2, Ki-67) expression in the diagnostic biopsies and the corresponding resected tumors in non-small cell lung cancerMEERT, Anne-Pascale; MARTIN, Benoit; VERDEBOUT, Jean-Marc et al.Lung cancer. 2004, Vol 44, Num 3, pp 295-301, issn 0169-5002, 7 p.Article

New targeted treatments in lung cancer: overview of clinical trialsKORFEE, S; GAULER, T; HEPP, R et al.Lung cancer. 2004, Vol 45, pp S199-S208, issn 0169-5002, SUP2Conference Paper

EGF-R and Her2/neu overexpressing tumors: independent collectives for treatment of breast cancer by specific monoclonal antibody-therapySOLBACH, Christine; ROLLER, Marc; BUDISCHEWSKI, Kai et al.Journal of cancer research and clinical oncology. 2003, Vol 129, Num 4, pp 250-251, issn 0171-5216, 2 p.Article

Corrélation entre l'expression d'EGF-R dans les biopsies et les pièces chirurgicales des cancers bronchiques = EGF-R expression correlation between biopsy and surgical specimens of lung carcinomaMEERT, A.-P; MARTIN, B; VERDEBOUT, J.-M et al.Revue des maladies respiratoires. 2003, Vol 20, Num 3, pp 347-353, issn 0761-8425, 7 p., CAH1Article

La place des thérapeutiques ciblées dans la prise en charge des CBNPC. Mécanismes biologiques de la carcinogenèse bronchique : D'une meilleure compréhension naissent les nouvelles thérapeutiques = The place of targeted therapies in the management of non-small cell bronchial carcinoma biological mechanisms of bronchial carcinogenesis : Towards a better understanding and the development of new therapiesZALCMAN, G; RICHARD, N; MADELAINE, J et al.Revue des maladies respiratoires. 2006, Vol 23, Num 5, issn 0761-8425, 16S123-16S130, CAH3Conference Paper

Epidermal growth factor receptor (EGF-R) in Dupuytren's diseaseAUGOFF, K; TABOŁA, R; KULA, J et al.Journal of hand surgery. British and european volume. 2005, Vol 30, Num 6, pp 570-573, 4 p.Article

Disruption of STAT3 signaling leads to tumor cell invasion through alterations of homotypic cell-cell adhesion complexesRIVAT, Christine; DE WEVER, Olivier; BRUYNEEL, Erik et al.Oncogene (Basingstoke). 2004, Vol 23, Num 19, pp 3317-3327, issn 0950-9232, 11 p.Article

Effects of a conditionally active v-ErbB and an EGF-R inhibitor on transformation of NIH-3T3 cells and abrogation of cytokine dependency of hematopoietic cellsMCCUBREY, James A; SHELTON, John G; STEELMAN, Linda S et al.Oncogene (Basingstoke). 2004, Vol 23, Num 47, pp 7810-7820, issn 0950-9232, 11 p.Article

Minimal residual disease detection in breast cancer: Improved sensitivity using cytokeratin 19 and epidermal growth factor receptor RT-PCRFELLOWES, Vicki S; HUSEBEKK, Anne; GRESS, Ronald E et al.International journal of oncology. 2004, Vol 24, Num 4, pp 861-867, issn 1019-6439, 7 p.Article

EGFR family signaling and its association with breast cancer development and resistance to chemotherapyNAVOLANIC, Patrick M; STEELMAN, Linda S; MCCUBREY, James A et al.International journal of oncology. 2003, Vol 22, Num 2, pp 237-252, issn 1019-6439, 16 p.Article

Construction of an EGF receptor-mediated histone H1⁰-based gene delivery systemDAI, Fei-Han; YAN CHEN; REN, Chang-Chun et al.Journal of cancer research and clinical oncology. 2003, Vol 129, Num 8, pp 456-462, issn 0171-5216, 7 p.Article

DRUG TREATMENT AND NOVEL DRUG TARGET AGAINST CRYPTOSPORIDIUMGARGALA, G.Parasite (Paris). 2008, Vol 15, Num 3, pp 275-281, issn 1252-607X, 7 p.Conference Paper

Dual inhibition of the epidermal growth factor and vascular endothelial growth factor phosphorylation for antivasculartherapy of human prostate cancer in the prostate of nude miceYAZICI, S; KIM, S. J; BUSBY, J. E et al.The Prostate. 2005, Vol 65, Num 3, pp 203-215, issn 0270-4137, 13 p.Article

Follikuläre Arzneimittelreaktion auf Cetuximab : Eine häufige Nebenwirkung bei der Therapie metastasierter kolorektaler Karzinome = Follicular drug reaction from cetuximab. A common side effect in the treatment of metastatic colon carcinomaBRAUN-FALCO, M; HOLTMANN, C; LORDICK, F et al.Hautarzt. 2006, Vol 57, Num 8, pp 701-704, issn 0017-8470, 4 p.Article

Therapy of multidrug resistant human prostate tumors in the prostate of nude mice by simultaneous targeting of the epidermal growth factor receptor and vascular endothelial growth factor receptor ontumor-associated endothelial cellsERIK BUSBY, J; KIM, Sun-Jin; FIDLER, Isaiah J et al.The Prostate. 2006, Vol 66, Num 16, pp 1788-1798, issn 0270-4137, 11 p.Article

Les voies de signalisation EGF R/PDGF R dans les métastases osseuses du cancer de prostate : leurs implications thérapeutiques potentielles = Potential therapeutic implications of EGF R/PDGF R signalling pathways in bone metastases of prostate cancerPAULE, Bernard.Progrès en urologie (Paris). 2005, Vol 15, Num 4, pp 616-620, issn 1166-7087, 5 p.Article

Antagonists of Growth Hormone Releasing Hormone (GHRH) and of Bombesin/Gastrin Releasing Peptide (BN/GRP) suppress the expression of VEGF, bFGF, and receptors of the EGF/HER family in PC -3 and DU-145 human androgen-lndependent prostate cancersSTANGELBERGER, Anton; SCHALLY, Andrew V; VARGA, Jozsef L et al.The Prostate. 2005, Vol 64, Num 3, pp 303-315, issn 0270-4137, 13 p.Article